- NuGen Medical Devices (NGMD) has applied to the TSX-V for a 30-day price protection extension to complete further subscriptions
- This is in connection with the private placement originally announced by the company on July 22, 2022
- The company plans the next tranche of the offering to close in the next couple weeks
- NuGen is an emerging specialty medical device company developing the next generation of needle-free technologies and other innovative medical delivery products
- Nugen Medical Devices Inc. was unchanged at $0.10 at 12:43 PM ET
NuGen Medical Devices (NGMD) has applied to the TSX-V for a 30-day price protection extension to complete further subscriptions.
The application is in connection with the private placement originally announced by the company on July 22, 2022.
The company plans the next tranche of the offering to close in the next couple weeks.
Further closing of the offering is subject to receipt of further subscriptions and all necessary corporate and regulatory approvals, including the approval of TSX Venture Exchange.
All securities issued in connection with the offering will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.
Certain insiders of the company may participate in the second tranche of the financing.
NuGen is an emerging specialty medical device company developing the next generation of needle-free technologies and other innovative medical delivery products.
The company’s products, which include the InsuJet and PetJet needle-free injection systems, are designed to improve the lives of millions of people and animals.
Nugen Medical Devices Inc. was unchanged at $0.10 at 12:43 PM ET.
